Skip to main content

Kathleen Beusterien, MPH

Principal, RWE

Cerner Enviza

Kathleen is Principal, RWE at Cerner Enviza, an Oracle Company. She has over 25 years of experience performing health outcomes research. Kathleen has consulted on a number of communications with the FDA and EMA regarding patient reported outcomes (PRO) endpoints in clinical trials and has developed PRO measures and dossiers for regulatory review. She has numerous preference and PRO publications and regularly leads workshops and presentations at scientific and industry conferences on these areas. She is a founding member of the International Academy of Health Preference Research (IAHPR). 

Product Type
On Demand

What is real world evidence in health and why is it so important to patients, Healthcare practitioners, Pharmaceutical Companies, and the FDA?

Total Credits: 1 Advance Credits

Average Rating:
Analysis & Reporting |  Research Design
Kathleen Beusterien, MPH |  Rebecca Nash |  Colleen Welsh-Allen
48 Minutes
Audio and Video
Original Program Date:
Dec 01, 2022
Short Description:
Qualitative research is critical in understanding the impact of disease and supporting new health interventions. Cerner Enviza, an Oracle company, will share the background on real world evidence, the...
$0.00 - Non-Member Price

Showing 1 to 1 of 1 entries